{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:09:34Z","timestamp":1783393774909,"version":"3.54.6"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T00:00:00Z","timestamp":1194480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T00:00:00Z","timestamp":1194480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00467-007-0643-7","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T14:00:30Z","timestamp":1194444030000},"page":"363-371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Hypertension in children with chronic kidney disease: pathophysiology and management"],"prefix":"10.1007","volume":"23","author":[{"given":"Charlotte","family":"Hadtstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,8]]},"reference":[{"key":"643_CR1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.ki.5001608","volume":"70","author":"H Wong","year":"2006","unstructured":"Wong H, Mylera K, Feber J, Drukker A, Filler G (2006) Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70:585\u2013590","journal-title":"Kidney Int"},{"key":"643_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0140-6736(96)09260-4","volume":"349","author":"AM Wingen","year":"1997","unstructured":"Wingen AM, Fabian-Bach C, Schaefer F, Mehls O, European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. Lancet 349:1117\u20131123","journal-title":"Lancet"},{"key":"643_CR3","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1097\/01.ASN.0000089565.04535.4B","volume":"14","author":"MM Mitsnefes","year":"2003","unstructured":"Mitsnefes MM, Ho PL, McEnery PT (2003) Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 14:2618\u20132622","journal-title":"J Am Soc Nephrol"},{"key":"643_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1046\/j.1523-1755.2002.00156.x","volume":"61","author":"JW Groothoff","year":"2002","unstructured":"Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and cause of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 61:621\u2013629","journal-title":"Kidney Int"},{"key":"643_CR5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/ndt\/gfi280","volume":"21","author":"M Tkaczyk","year":"2006","unstructured":"Tkaczyk M, Nowicki M, Balasz-Chmielewska I, Boguszewska-Baczkowska H, Drozdz D, Kollataj B, Jarmolinski T, Jobs K, Killis-Pstrusinska K, Leszczynska B, Makulska I, Runowski D, Stankiewicz R, Szczepanska M, Wiercinski R, Grenda R, Kanik A, Pietrzyk JA, Roszkowska-Blaim M, Szprynger K, Zachwieja J, Zajaczkowska MM, Zoch-Zwierz W, Zwolinska D, Zurowska A (2006) Hypertension in dialysed children: the prevalence and therapeutic approach in Poland\u2014a nationwide survey. Nephrol Dial Transplant 21:736\u2013742","journal-title":"Nephrol Dial Transplant"},{"key":"643_CR6","first-page":"57","volume":"5","author":"H Brass","year":"1976","unstructured":"Brass H, Ochs HG, Armbruster H, Heintz R (1976) Plasma renin activity (PRA) and aldosterone (PA) in patients with chronic glomerulonephritis (GN) and hypertension. Clin Nephrol 5:57\u201360","journal-title":"Clin Nephrol"},{"key":"643_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0140-6736(70)90404-6","volume":"1","author":"DJ Warren","year":"1970","unstructured":"Warren DJ, Ferris TF (1970) Renin secretion in renal hypertension. Lancet 1:159\u2013162","journal-title":"Lancet"},{"key":"643_CR8","doi-asserted-by":"publisher","first-page":"F775","DOI":"10.1152\/ajprenal.00370.2003","volume":"287","author":"M Loghman-Adham","year":"2004","unstructured":"Loghman-Adham M, Soto CE, Inagami T, Cassis L (2004) The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol 287:F775\u2013F788","journal-title":"Am J Physiol Renal Physiol"},{"key":"643_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1681\/ASN.V9172","volume":"9","author":"HN Ibrahim","year":"1998","unstructured":"Ibrahim HN, Hostetter TH (1998) The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol 9:72\u201376","journal-title":"J Am Soc Nephrol"},{"key":"643_CR10","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1159\/000066656","volume":"93","author":"G Wolf","year":"2003","unstructured":"Wolf G, Butzmann U, Wenzel UO (2003) The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 93:P3\u2013P13","journal-title":"Nephron Physiol"},{"key":"643_CR11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0272-6386(99)70217-9","volume":"33","author":"JM Sorof","year":"1999","unstructured":"Sorof JM, Brewer ED, Portmann RJ (1999) Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis. Am J Kidney Dis 33:667\u2013674","journal-title":"Am J Kidney Dis"},{"key":"643_CR12","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0272-6386(98)70147-7","volume":"32","author":"B Charra","year":"1998","unstructured":"Charra B, Bergstr\u00f6m J, Scribner BH (1998) Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 32:720\u2013724","journal-title":"Am J Kidney Dis"},{"key":"643_CR13","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","volume":"12","author":"IH Klein","year":"2001","unstructured":"Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ (2001) Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 12:2427\u20132433","journal-title":"J Am Soc Nephrol"},{"key":"643_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000429265","volume":"41","author":"P Weidmann","year":"1984","unstructured":"Weidmann P (1984) Pathogenesis of hypertension associated with chronic renal failure. Contrib Nephrol 41:47\u201365","journal-title":"Contrib Nephrol"},{"key":"643_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ki.1997.103","volume":"51","author":"S Ye","year":"1997","unstructured":"Ye S, Ozgur B, Campese VM (1997) Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51:722\u2013727","journal-title":"Kidney Int"},{"key":"643_CR16","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","volume":"340","author":"G Ligtenberg","year":"1999","unstructured":"Ligtenberg G, Blankenstijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA (1999) Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 340:1321\u20131328","journal-title":"N Engl J Med"},{"key":"643_CR17","doi-asserted-by":"crossref","first-page":"I240","DOI":"10.1161\/01.HYP.23.1_Suppl.I240","volume":"23","author":"OG Kuchel","year":"1994","unstructured":"Kuchel OG, Shigetomi S (1994) Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency. Hypertension 23:I240\u2013I245","journal-title":"Hypertension"},{"key":"643_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/ajkd.2002.32799","volume":"39","author":"G Wolf","year":"2002","unstructured":"Wolf G, Chen S, Han DC, Ziyadeh FN (2002) Leptin and renal disease. Am J Kidney Dis 39:1\u201311","journal-title":"Am J Kidney Dis"},{"key":"643_CR19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5414\/CNP61316","volume":"61","author":"K Tory","year":"2004","unstructured":"Tory K, Horv\u00e1th E, S\u00fcveges Z, Fekete A, Sallay P, Berta K, Szab\u00f3 T, Szab\u00f3 AJ, Tulassay T, Reusz GS (2004) Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo controlled, randomized crossover pilot trial. Clin Nephrol 61:316\u2013323","journal-title":"Clin Nephrol"},{"key":"643_CR20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.HYP.17.6.1057","volume":"17","author":"E Miyajima","year":"1991","unstructured":"Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, Ishii M (1991) Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 17:1057\u20131062","journal-title":"Hypertension"},{"key":"643_CR21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.RES.57.5.676","volume":"57","author":"JE Faber","year":"1985","unstructured":"Faber JE, Brody MA (1985) Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res 57:676\u2013688","journal-title":"Circ Res"},{"key":"643_CR22","first-page":"S27","volume":"15","author":"W Rauh","year":"1983","unstructured":"Rauh W, Hund E, Sohl G, Rascher W, Mehls O, Sch\u00e4rer K (1983) Vasoactive hormones in children with chronic renal failure. Kidney Int Suppl 15:S27\u2013S33","journal-title":"Kidney Int Suppl"},{"key":"643_CR23","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1172\/JCI200524066","volume":"115","author":"J Xu","year":"2005","unstructured":"Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, Wu Y, Peixoto A, Crowley S, Desir GV (2005) Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest 115:1275\u20131280","journal-title":"J Clin Invest"},{"key":"643_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00702-007-0672-1","volume":"114","author":"F Boomsma","year":"2007","unstructured":"Boomsma F, Tipton KF (2007) Renalase, a catecholamine-metabolising enzyme? J Neural Transm 114:775\u2013776","journal-title":"J Neural Transm"},{"key":"643_CR25","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1681\/ASN.2005121379","volume":"17","author":"K Matsuguma","year":"2006","unstructured":"Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S (2006) Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol 17:2176\u20132183","journal-title":"J Am Soc Nephrol"},{"key":"643_CR26","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","volume":"358","author":"C Zoccali","year":"2001","unstructured":"Zoccali C, Bode-B\u00f6ger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotto A, Bellanuova I, Fermo I, Fr\u00f6lich J, B\u00f6ger R (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113\u20132117","journal-title":"Lancet"},{"key":"643_CR27","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1681\/ASN.2005050539","volume":"16","author":"D Fliser","year":"2005","unstructured":"Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-B\u00f6ger SM, Haller H, Ritz E (2005) Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 16:2254\u20132256","journal-title":"J Am Soc Nephrol"},{"key":"643_CR28","doi-asserted-by":"crossref","first-page":"F642","DOI":"10.1152\/ajprenal.1998.274.4.F642","volume":"274","author":"ND Vaziri","year":"1998","unstructured":"Vaziri ND, Ni X, Wang Q, Oveisi F, Zhou XJ (1998) Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH. Am J Physiol Renal Physiol 274:F642\u2013F649","journal-title":"Am J Physiol Renal Physiol"},{"key":"643_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/ki.1993.100","volume":"43","author":"AE Raine","year":"1993","unstructured":"Raine AE, Bedford L, Simpson AW, Ashley CC, Brown R, Woodhead JS, Ledingham JG (1993) Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 43:700\u2013705","journal-title":"Kidney Int"},{"key":"643_CR30","first-page":"924","volume":"250","author":"K Iseki","year":"1986","unstructured":"Iseki K, Massry SG, Campese VM (1986) Effects of hypercalcemia and parathyroid hormone on blood pressure in normal and renal failure rats. Am J Physiol 250:924\u2013929","journal-title":"Am J Physiol"},{"key":"643_CR31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0272-6386(93)70095-G","volume":"21","author":"H Schiffl","year":"1993","unstructured":"Schiffl H, Fricke H, Sitter T (1993) Hypertension secondary to early-stage kidney disease: the pathogenetic role of altered cytosolic calcium (Ca2+) homeostasis of vascular smooth muscle cells. Am J Kidney Dis 21:51\u201357","journal-title":"Am J Kidney Dis"},{"key":"643_CR32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ki.1995.113","volume":"47","author":"RG Carlini","year":"1995","unstructured":"Carlini RG, Reyes AA, Rothstein M (1995) Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47:740\u2013745","journal-title":"Kidney Int"},{"key":"643_CR33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0272-6386(99)70413-0","volume":"33","author":"ND Vaziri","year":"1999","unstructured":"Vaziri ND (1999) Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis 33:821\u2013828","journal-title":"Am J Kidney Dis"},{"key":"643_CR34","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.HYP.32.4.724","volume":"32","author":"Z Ni","year":"1988","unstructured":"Ni Z, Wang XQ, Vaziri ND (1988) Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade. Hypertension 32:724\u2013729","journal-title":"Hypertension"},{"key":"643_CR35","doi-asserted-by":"publisher","first-page":"229S","DOI":"10.1016\/j.transproceed.2004.01.021","volume":"36","author":"A Busauschina","year":"2004","unstructured":"Busauschina A, Schnuelle P, van der Woude FJ (2004) Cyclosporine nephrotoxicity. Transplant Proc 36:229S\u2013233S","journal-title":"Transplant Proc"},{"key":"643_CR36","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1093\/ndt\/gfm390","volume":"22","author":"C Esteva-Font","year":"2007","unstructured":"Esteva-Font C, Ars E, Guillen-Gomez E, Campistol JM, Sanz L, Jim\u00e9nez W, Knepper MA, Torres F, Torra R, Ballarin JA, Fern\u00e1ndez-Llama P (2007) Cyclosporine-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2). Nephrol Dial Transplant 22:2810\u20132816","journal-title":"Nephrol Dial Transplant"},{"key":"643_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1034\/j.1399-3046.2003.00079.x","volume":"7","author":"AM Neu","year":"2003","unstructured":"Neu AM, Ho PL, Fine RN, Furth SL, Fivush BA (2003) Tacrolimus vs cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study. Pediatr Transplant 7:217\u2013222","journal-title":"Pediatr Transplant"},{"key":"643_CR38","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/ndt\/gfi274","volume":"21","author":"MD Sinha","year":"2006","unstructured":"Sinha MD, MacLeod R, Rigby E, Clark AG (2006) Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Nephrol Dial Transplant 21:1761\u20131763","journal-title":"Nephrol Dial Transplant"},{"key":"643_CR39","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1210\/jc.87.4.1743","volume":"87","author":"G Johannson","year":"2002","unstructured":"Johannson G, Sverrisd\u00f3ttir YB, Ellegard L, Lundberg PA, Herlitz H (2002) GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis. J Clin Endocrinol Metab 87:1743\u20131749","journal-title":"J Clin Endocrinol Metab"},{"key":"643_CR40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/BF01453681","volume":"5","author":"B T\u00f6nshoff","year":"1991","unstructured":"T\u00f6nshoff B, Heinrich U, Mehls O (1991) How safe is the treatment of uraemic children with recombinant human growth hormone? Pediatr Nephrol 5:454\u2013460","journal-title":"Pediatr Nephrol"},{"key":"643_CR41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1046\/j.1365-2265.2000.00961.x","volume":"52","author":"D Nathwani","year":"2002","unstructured":"Nathwani D, Unwin R, Brook CG, Hindmarsh PC (2002) The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome. Clin Endocrinol (Oxf) 52:371\u2013377","journal-title":"Clin Endocrinol (Oxf)"},{"key":"643_CR42","first-page":"S1","volume":"43","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI) Group","year":"2004","unstructured":"Kidney Disease Outcomes Quality Initiative (K\/DOQI) Group (2004) K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43:S1\u2013S290","journal-title":"Am J Kidney Dis"},{"key":"643_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1053\/j.ajkd.2004.11.006","volume":"45","author":"M Mitsnefes","year":"2005","unstructured":"Mitsnefes M, Stablein D (2005) Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 45:309\u2013315","journal-title":"Am J Kidney Dis"},{"key":"643_CR44","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1203\/01.PDR.0000106863.90996.76","volume":"55","author":"E W\u00fchl","year":"2004","unstructured":"W\u00fchl E, Hadtstein C, Mehls O, Schaefer F, ESCAPE trial group (2004) Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 55:492\u2013497","journal-title":"Pediatr Res"},{"key":"643_CR45","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/01.HYP.0000160320.39303.ab","volume":"45","author":"E Lurbe","year":"2005","unstructured":"Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen J (2005) Prevalence, persistence and clinical significance of masked hypertension in youth. Hypertension 45:493\u2013398","journal-title":"Hypertension"},{"key":"643_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555\u2013576","journal-title":"Pediatrics"},{"key":"643_CR47","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Barkis GL, Black DL, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560\u20132571","journal-title":"JAMA"},{"key":"643_CR48","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1097\/00004872-200210000-00019","volume":"20","author":"E W\u00fchl","year":"2002","unstructured":"W\u00fchl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension (2002) Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995\u20132007","journal-title":"J Hypertens"},{"key":"643_CR49","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/HJH.0b013e328122d3fc","volume":"25","author":"GS Stergiou","year":"2007","unstructured":"Stergiou GS, Yiannes NG, Rarra VC, Panagiotakos DB (2007) Home blood pressure normalcy in children and adolescents: the Arsakeion school study. J Hypertens 25:1375\u20131379","journal-title":"J Hypertens"},{"key":"643_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.2005030276","volume":"17","author":"MC Matteucci","year":"2006","unstructured":"Matteucci MC, W\u00fchl E, Picca S, Mastrostefano A, Rinelli G, Romano C, Rizzoni G, Mehls O, de Simone G, Schaefer F (2006) Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 17:218\u2013226","journal-title":"J Am Soc Nephrol"},{"key":"643_CR51","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1681\/ASN.2004110932","volume":"16","author":"M Litwin","year":"2005","unstructured":"Litwin M, W\u00fchl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Tr\u00f6ger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494\u20131500","journal-title":"J Am Soc Nephrol"},{"key":"643_CR52","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/01.hjh.0000178834.26353.d5","volume":"23","author":"C Jourdan","year":"2005","unstructured":"Jourdan C, W\u00fchl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk J, Grenda R, Mehls O, Tr\u00f6ger J, Schaefer F (2005) Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707\u20131715","journal-title":"J Hypertens"},{"key":"643_CR53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/ajkd.2002.30542","volume":"39","author":"MP H\u00f6rl","year":"2002","unstructured":"H\u00f6rl MP, H\u00f6rl WH (2002) Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 39:227\u2013244","journal-title":"Am J Kidney Dis"},{"key":"643_CR54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0272-6386(99)70346-X","volume":"34","author":"M Ozkahya","year":"1999","unstructured":"Ozkahya M, Toz H, Unsal A, Ozerkan F, Asci G, Gurgun C, Akcicek F, Mees FJ (1999) Treatment of hypertension in dialysis patients by ultrafiltration: role of cardiac dilatation and time factor. Am J Kidney Dis 34:218\u2013222","journal-title":"Am J Kidney Dis"},{"key":"643_CR55","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1093\/ndt\/gfm220","volume":"22","author":"H Thein","year":"2007","unstructured":"Thein H, Haloob I, Marshall MR (2007) Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain. Nephrol Dial Transplant 22:2630\u20132639","journal-title":"Nephrol Dial Transplant"},{"key":"643_CR56","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/ndt\/13.3.552","volume":"13","author":"S Krautzig","year":"1998","unstructured":"Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S (1998) Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 13:552\u2013553","journal-title":"Nephrol Dial Transplant"},{"key":"643_CR57","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/j.1550-8528.1996.tb00250.x","volume":"4","author":"R Figueroa-Colon","year":"1996","unstructured":"Figueroa-Colon R, Franklin FA, Lee JY, von Almen TK, Suskind RM (1996) Feasibility of a clinic-based hypocaloric dietary intervention implemented in a school setting for obese children. Obes Res 4:419\u2013429","journal-title":"Obes Res"},{"key":"643_CR58","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJM198908313210905","volume":"321","author":"AP Rocchini","year":"1989","unstructured":"Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M (1989) The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321:580\u2013585","journal-title":"N Engl J Med"},{"key":"643_CR59","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","volume":"349","author":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)","year":"1997","unstructured":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857\u20131863","journal-title":"Lancet"},{"key":"643_CR60","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00467-006-0293-1","volume":"22","author":"MG Bianchetti","year":"2007","unstructured":"Bianchetti MG, Ammenti A, Avolio L, Bettinelli A, Bosio M, Fossali E, la Manna A, Maringhini S, Pela I, Ratsch IM, Vigan\u00f2 S, Ardissino G, Italkid Project, CHIld Project (2007) Prescription of drugs blocking the renin-angiotensin system in Italian children. Pediatr Nephrol 22:144\u2013148","journal-title":"Pediatr Nephrol"},{"key":"643_CR61","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00467-004-1804-6","volume":"20","author":"RP Woroniecki","year":"2005","unstructured":"Woroniecki RP, Flynn JT (2005) How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists. Pediatr Nephrol 20:791\u2013797","journal-title":"Pediatr Nephrol"},{"key":"643_CR62","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1523-1755.2004.00802.x","volume":"66","author":"E W\u00fchl","year":"2004","unstructured":"W\u00fchl E, Mehls O, Schaefer F, ESCAPE trial group (2004) Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66:768\u2013776","journal-title":"Kidney Int"},{"key":"643_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","volume":"361","author":"N Nakao","year":"2003","unstructured":"Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T (2003) Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 361:117\u2013124","journal-title":"Lancet"},{"key":"643_CR64","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1046\/j.1523-1755.2003.00832.x","volume":"63","author":"R Campbell","year":"2003","unstructured":"Campbell R, Sangalli F, Perticucci E, Aros C, Viscarra C, Perna A, Remuzzi A, Bertocchi F, Fagiani L, Remuzzi G, Ruggenenti P (2003) Effects of combined ACE inhibitor and angiotensin\u00a0II antagonist treatment in human chronic nephropathies. Kidney Int 63:1094\u20131103","journal-title":"Kidney Int"},{"key":"643_CR65","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1442-200x.2004.01955.x","volume":"46","author":"H Tanaka","year":"2004","unstructured":"Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Konno Y, Tsuruga K, Ito E, Waga S (2004) Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy. Pediatr Int 46:576\u2013579","journal-title":"Pediatr Int"},{"key":"643_CR66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5414\/CNP64035","volume":"64","author":"Y Yang","year":"2005","unstructured":"Yang Y, Ohta K, Shimizu M, Nakai A, Kasahara Y, Yachie A, Koizumi S (2005) Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin\u00a0II receptor blocker (ARB) in pediatric patients with IgA nephropathy. Clin Nephrol 64:35\u201340","journal-title":"Clin Nephrol"},{"key":"643_CR67","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1542\/peds.2005-2053","volume":"118","author":"R Lubrano","year":"2006","unstructured":"Lubrano R, Soscia F, Elli M, Ventrigilia F, Raggi C, Travasso E, Scateni S, Di Maio V, Versacci P, Masciangelo R, Romero S (2006) Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin\u00a0II receptor antagonist therapy in children with proteinuria. Pediatrics 118:e833\u2013e838","journal-title":"Pediatrics"},{"key":"643_CR68","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s00467-006-0223-2","volume":"21","author":"M Litwin","year":"2006","unstructured":"Litwin M, Grenda R, Sladowska J, Antoniewicz J (2006) Add-on therapy with angiotensin\u00a0II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors. Pediatr Nephrol 21:1716\u20131722","journal-title":"Pediatr Nephrol"},{"key":"643_CR69","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1592\/phco.26.9.1348","volume":"26","author":"CD Hanevold","year":"2006","unstructured":"Hanevold CD (2006) Acute renal failure during lisinopril and losartan therapy for proteinuria. Pharmacotherapy 26:1348\u20131351","journal-title":"Pharmacotherapy"},{"key":"643_CR70","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","volume":"139","author":"TH Jafar","year":"2003","unstructured":"Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS, AIPRD study group (2003) Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-meta-analysis. Ann Intern Med 139:244\u2013252","journal-title":"Ann Intern Med"},{"key":"643_CR71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","volume":"135","author":"TH Jafar","year":"2001","unstructured":"Jafar TH, Schmid CH, Landa M, Giatras J, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, DeJong P, DeZeeuw D, Lau J, Levey AS, ACE Inhibition in Progressive Renal Disease Study Group (2001) Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135:73\u201387","journal-title":"Ann Intern Med"},{"key":"643_CR72","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1046\/j.1523-1755.63.s83.15.x","volume":"83","author":"JG Douglas","year":"2003","unstructured":"Douglas JG, Agoda L (2003) ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American study of kidney disease and hypertension (AASK) trial. Kidney Int Suppl 83:S74\u2013S76","journal-title":"Kidney Int Suppl"},{"key":"643_CR73","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/ki.1996.480","volume":"50","author":"GL Bakris","year":"1996","unstructured":"Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S (1996) Calcium channel blockers vs other antihypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 50:1641\u20131650","journal-title":"Kidney Int"},{"key":"643_CR74","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2165\/00148581-200608060-00004","volume":"8","author":"S Sahney","year":"2006","unstructured":"Sahney S (2006) A review of calcium channel antagonists in the treatment of pediatric hypertension. Paediatr Drugs 8:357\u2013373","journal-title":"Paediatr Drugs"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0643-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-007-0643-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0643-7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-007-0643-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T19:25:45Z","timestamp":1630437945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-007-0643-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,8]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s00467-007-0643-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,8]]},"assertion":[{"value":"9 August 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}